See if Buzzy and virtual reality help kids get IV lines faster
Official title: The Effect of Buzzy and VR on Procedure Duration, Pain, Fear, and Parental Anxiety in Children Undergoing Venous Imaging
Run by Bandırma Onyedi Eylül University · NCT07882602 · Data updated 2026-11-12
This study tests whether a vein-imaging device plus virtual reality or the same device plus a pain-reducing tool can make peripheral IV placement easier for children aged 7–12 with fever.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years to 12 Years |
| Sex | All |
| Enrollment | 105 (estimated) |
| Sponsor | Bandırma Onyedi Eylül University Academic / other |
| Locations | 1 site (Bursa) |
| Status | Recruiting |
| Started | February 6, 2026 |
| Main results expected | December 2026 |
| Study ends | January 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07882602 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 7–12 with fever undergoing a planned venous access procedure.
✕Probably not a fit
Children outside the 7–12 age range or those not experiencing fever may not benefit from these interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial investigates two interventions designed to ease venous access in pediatric patients during fever episodes. Participants aged 7 to 12 undergoing peripheral IV catheterization are randomized to receive either a vein-imaging device with a virtual reality headset or a vein-imaging device with a Buzzy device for pain distraction. The aim is to see whether these approaches reduce procedural difficulty, pain, and anxiety compared with standard care. The study is conducted at Karacabey State Hospital in Bursa, Turkey, led by Bandırma Onyedi Eylül University. Enrollment requires parental consent and fever above 37.5°C; exclusion criteria include prior analgesic use for the procedure, complete dehydration, or parental withdrawal.
Why it matters
Potential benefit: If successful, the methods could reduce pain, fear, and time needed for IV access in children during fever.
How similar studies have gone: Previous pediatric venipuncture studies suggest similar distraction and imaging approaches can ease access, but this specific combination in febrile kids is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The child must be between the ages of 7 and 12. * Written consent from the parents indicating their voluntary participation in the study. * The child must have a fever (\>37.5°C). Exclusion Criteria: * Parents wishing to withdraw from the study at any stage * The patient having taken antipyretic or analgesic medications prior to the PIVC procedure * The presence of severe dehydration
Where it's running
-
Karacabey state hospital
Bursa, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Zübeyde Ezgi ERÇELİK, Assistant Professor, PhD
- Email: zezgiozgenn5@gmail.com
- Phone: +90 (0266) 717 01 17
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Triage performance and physiological predictors of serious illness in febrile children in the pediatric emergency department
This study tests whether the initial color-coded triage category and vital signs at triage can predict serious outcomes in febrile children who come to pediatric emergency departments in Turkey.
-
Turning anonymous symptom descriptions into structured biological signals with OpenGenome
This project tries to turn adults' anonymous free-text symptom descriptions submitted to OpenGenome into structured, literature-grounded biological signals using PubMed and ClinicalTrials.gov sources and a constrained reasoning model.
-
How long to take sulfamethoxazole after a kidney transplant
This study will test whether different lengths of sulfamethoxazole (TMP‑SMX) taken after a kidney transplant better prevent Pneumocystis jirovecii pneumonia in adult transplant recipients.
-
Safety of giving an RSV preventive antibody with routine childhood vaccines
This trial will test whether giving an RSV preventive antibody at the same visit as routine childhood vaccines is as safe for infants 6 to <30 weeks old as giving the antibody at a separate visit.
-
Providing weight-based prescriptions for fever medicine to reduce emergency department return visits for young children.
This will test if giving caregivers weight-based prescriptions for acetaminophen and ibuprofen to children aged 6 to 35 months when they leave the ED reduces unscheduled return visits within one week.
-
Point-of-care fingertip CRP testing to guide care for febrile children
We will test a small fingertip (capillary) C‑reactive protein (CRP) test in primary care to help doctors decide care for children with fever who need a CRP measurement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.